Lilly’s retatrutide shows greater efficacy than Ozempic in trial

Earnings call transcript: BASF beats Q3 2026 estimates, narrows outlook

Investing.com · News 14m ago

StrongPoint Q3 2026 slides: revenue jumps 14%, recurring base slips

Investing.com · News 14m ago

Why is F5 stock sliding today?

Investing.com · News 15m ago

JPMorgan reiterates ArcelorMittal stock rating on earnings outlook

Investing.com · News 16m ago

Oppenheimer downgrades Enphase Energy stock rating on weak demand

Investing.com · News 16m ago

Jio’s Blockbuster I.P.O. Gives India’s Investors a Lift

The New York Times · Business 17m ago

The ‘Buy, Borrow and Die’ Wealth Strategy Gains in Popularity

Dow Jones · Markets 17m ago

GE Vernova to Buy High-Voltage Grid Equipment Manufacturer for $9 Billion

Dow Jones · Markets 18m ago

Vertiv Raises 2026 Guidance

NASDAQ · Markets 19m ago

Earnings call transcript: Corbion posts strong Q3 2026, but shares fall

Investing.com · News 20m ago